Skip to main content

Month: September 2022

Prosafe SE: Safe Boreas extended on UK contract

The client chartering the Safe Boreas to provide gangway connected operations to support a platform shutdown in the UK North Sea has exercised the first of two 15-day options. The value of the extended period is approximately USD 2.1 million. Prosafe is a leading owner and operator of semi-submersible accommodation vessels. The company is listed on the Oslo Stock Exchange with ticker code PRS. For more information, please refer to https://www.prosafe.com Stavanger, 30 September 2022 Prosafe SE For further information, please contact: Jesper K. Andresen, CEO Phone: +47 51 65 24 30 / +47 907 65 155 Reese McNeel, CFOPhone: +47 47 51 64 25 17 / +47 415 08 186 This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act

Continue reading

Pharvaris Announces the Promotion of Annick Deschoolmeester to Chief Human Resources Officer

ZUG, Switzerland, Sept. 30, 2022 (GLOBE NEWSWIRE) — Pharvaris (Nasdaq: PHVS), a clinical-stage company developing novel, oral bradykinin-B2-receptor antagonists to treat and prevent hereditary angioedema (HAE) attacks, today announced the promotion of Annick Deschoolmeester to Chief Human Resources Officer. Ms. Deschoolmeester will be responsible for overseeing Pharvaris’ people strategy, including talent acquisition and management, employee relations, leadership development, compensation and benefits, and diversity and inclusion. “Annick’s deep experience in human resources, specifically within strategic organizational growth, has had an immediate and substantial impact on Pharvaris,” said Berndt Modig, Chief Executive Officer of Pharvaris. “In the past year, Annick has been instrumental to positioning Pharvaris for its next stage...

Continue reading

Immuneering Announces FDA Clearance of IND Application for Phase 1/2a Clinical Trial of IMM-1-104 to Treat Advanced Solid Tumors with RAS Mutations

Initiation of Phase 1/2a Clinical Trial Expected to Occur in Q4 2022 CAMBRIDGE, Mass., Sept. 30, 2022 (GLOBE NEWSWIRE) — Immuneering Corporation (Nasdaq: IMRX), a biopharmaceutical company that aims to create medicines for all patients with solid tumors driven by RAS mutations and other MAPK pathway activation events, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for IMM-1-104, paving the way for the company to initiate a Phase 1/2a clinical trial of this oral, once daily small molecule, in development for the treatment of advanced RAS mutant solid tumors. “Clearance of the IND for IMM-1-104 brings us one step closer to our goal of developing medicines with the potential to benefit every cancer patient with a RAS mutant solid tumor, not just those harboring...

Continue reading

Konsolidator secures funding until the end of August 2023

Company announcement no 14-2022 Søborg, September 30, 2022Konsolidator secures funding until the end of August 2023 Konsolidator raises DKK 5 million in capital in a combination of directed issue to a current shareholder in the amount of DKK 3 million and a credit facility at the bank of DKK 2 million. A tight cost focus and continued growth will secure enough funding until the end of August 2023. Directed share issueThe board of directors of Konsolidator has today exercised its authorisation to increase the share capital in a directed issue without pre-emption rights for Konsolidator’s existing shareholders according to article 3.1.1. of the articles of association. The new shares issued in connection with the directed issue will be subscribed by a current shareholder. Consequently, the board of directors has resolved to issue a total...

Continue reading

GigaCloud Technology Inc Announces Second Quarter 2022 Financial Results

HONG KONG, Sept. 30, 2022 (GLOBE NEWSWIRE) — GigaCloud Technology Inc (Nasdaq: GCT) (“GigaCloud” or the “Company”), a pioneer of global end-to-end B2B ecommerce solutions for large parcel merchandise, today announced its unaudited financial results for the quarter and six months ended June 30, 2022. Mr. Larry Lei Wu, Founder, Chairman of the Board of Director and Chief Executive Officer of GigaCloud, commented, “We are pleased to deliver a robust financial and operational results in our first quarterly earnings release as a public company. Our Nasdaq listing in August represented a key milestone for our Company and years of hard-work, commitment and dedication from our shareholders, management team and employees. Despite the macroeconomic challenges that we faced, we continued to deliver a solid year over year revenue and GMV growth....

Continue reading

Aurora Mobile’s Subsidiary SendCloud Provides Email Service to DHgate.com

SHENZHEN, China, Sept. 30, 2022 (GLOBE NEWSWIRE) — Aurora Mobile Limited (NASDAQ: JG) (“Aurora Mobile” or the “Company”), a leading provider of customer engagement and marketing technology services in China, today announced that its subsidiary Wuhan SendCloud Technology Co., Ltd. (“SendCloud”) has entered into a strategic partnership with DHgate.com, a leading B2B cross-border e-commerce online transaction service platform in China. Leveraging its cutting-edge email technology, SendCloud will provide DHgate.com with high-efficiency email services. This partnership is further validation of the industry-wide acclaim and trust that SendCloud commands for the high-quality services it offers to cross-border e-commerce platforms. DHgate.com is a subsidiary of DHGATE Group, which was founded by Ms. Diane Wang, Chairperson and CEO of DHGATE...

Continue reading

Rule 8.3 – Capital & Counties Properties Plc

FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1.        KEY INFORMATION  (a)        Full name of discloser: Investec Wealth & Investment Limited(b)        Owner or controller of interests and short positions disclosed, if different from 1(a):         The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.N/A(c)        Name of offeror/offeree in relation to whose relevant securities this form relates:         Use a separate form for each offeror/offereeCapital & Counties Properties Plc(d)        If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)        Date...

Continue reading

Swiss Properties Invest A/S half-yearly financial rapport for the period 1 January 2022 to 30 June 2022

Swiss Properties Invest A/S half-yearly financial report for the period 1st January 2022 to 30th June 2022. Company Announcement No. 3-2022 Copenhagen, 30 September 2022 Today the board of directors of Swiss Properties Invest A/S has approved the company’s half-yearly financial report for the period 1 January 2022 to 30 June 2022. Thorbjørn Graarud, Chairman of the Board of Directors: “Swiss Properties Invest A/S has published its first half-yearly report as a publicly traded company, and we are very pleased with the results delivered during the first half of 2022. We have worked hard to successfully complete the IPO of Swiss Properties Invest A/S and raise DKK 215 million during challenging times on the financial markets. With the completion of the IPO, we can now focus on finding attractive commercial properties and work hard to repay...

Continue reading

Changes to the Financial Calendar 2022/23

Changes to the Financial Calendar 2022/23 The date for the announcement of the Q1 Interim Management Statement 2022/23 has been changed from 14 November 2022 as previously announced to 11 November 2022. The date for the announcement of the Annual Report for 2022/23 has been changed from 8 September 2023 as previously announced to 19 September 2023. The Financial Calendar for 2022/23 after the changes is as follows: 9 September 2022, Annual Report 2021/22 24 October 2022, Annual General Meeting in Rovsing A/S 11 November 2022, Interim Management Statement Q1 2022/23 21 February 2023, Interim Report for H1 2022/23 15 May 2023, Interim Management Statement for Q3 2022/23 19 September 2023, Annual Report 2022/23 24 October 2023, Annual General Meeting in Rovsing A/S Further information: Sigurd Hundrup, CFO. Tel. +45 53 39 18 92. Email: shu@rovsing.dk...

Continue reading

TAAT® Hosting Exhibitor Booth and Two Private Events at the 2022 NACS Show in Las Vegas

Picture 1 At the NACS Show 2022, the TAAT® booth is located in the North Hall near the booths of well-known global brands in the convenience category to include JUUL Labs and Red Bull North America. In addition to this presence at the NACS Show, TAAT® will be hosting two private events in resorts on the Las Vegas Strip for executives from the convenience industry.LAS VEGAS and VANCOUVER, British Columbia, Sept. 30, 2022 (GLOBE NEWSWIRE) — TAAT® GLOBAL ALTERNATIVES INC. (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP) (the “Company” or “TAAT®”) is pleased to announce that it will be hosting an exhibitor booth at the 2022 trade show held by the National Association of Convenience Stores (“NACS”, event known as the “NACS Show”), during which time TAAT® will also be holding two private events for “top-to-top” meetings with executives...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.